Source
Market Research Future
As per analysis, the India Sickle Cell Disease Market is projected to grow from USD 0.259 Billion in 2024 to USD 0.294 Billion in 2025, ultimately reaching USD 0.92 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 12.22% during the forecast period (2025 - 2035).
Key Market Trends & Highlights
The India Sickle Cell Disease Market is poised for growth driven by advancements in treatment and increased awareness.
- The Blood Transfusion segment remains the largest contributor to the market, reflecting a critical need for ongoing patient care.
- Gene Therapy is emerging as the fastest-growing segment, indicating a shift towards innovative curative approaches.
- Curative Treatment continues to dominate the market, while Preventive Treatment is gaining traction as awareness increases.
- Government initiatives and rising prevalence of Sickle Cell Disease are key drivers propelling market expansion.
News Url